Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease : From the CREDO-Kyoto PCI/CABG registry Cohort-3
AIMS: There is a scarcity of studies comparing percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES) with coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease.
METHODS AND RESULTS: The CREDO-Kyoto PCI/CABG registry Cohort-3 enrolled 14927 consecutive patients who underwent first coronary revascularization with PCI or isolated CABG between January 2011 and December 2013. The current study population consisted of 2464 patients who underwent multi-vessel coronary revascularization including revascularization of left anterior descending coronary artery (LAD) either with PCI using new-generation DES (N = 1565), or with CABG (N = 899). Patients in the PCI group were older and more often had severe frailty, but had less complex coronary anatomy, and less complete revascularization than those in the CABG group. Cumulative 5-year incidence of a composite of all-cause death, myocardial infarction or stroke was not significantly different between the 2 groups (25.0% versus 21.5%, P = 0.15). However, after adjusting confounders, the excess risk of PCI relative to CABG turned to be significant for the composite endpoint (HR 1.27, 95%CI 1.04-1.55, P = 0.02). PCI as compared with CABG was associated with comparable adjusted risk for all-cause death (HR 1.22, 95%CI 0.96-1.55, P = 0.11), and stroke (HR 1.17, 95%CI 0.79-1.73, P = 0.44), but with excess adjusted risk for myocardial infarction (HR 1.58, 95%CI 1.05-2.39, P = 0.03), and any coronary revascularization (HR 2.66, 95%CI 2.06-3.43, P<0.0001).
CONCLUSIONS: In this observational study, PCI with new-generation DES as compared with CABG was associated with excess long-term risk for major cardiovascular events in patients who underwent multi-vessel coronary revascularization including LAD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
PloS one - 17(2022), 9 vom: 12., Seite e0267906 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.10.2022 Date Revised 04.10.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.1371/journal.pone.0267906 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346895693 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346895693 | ||
| 003 | DE-627 | ||
| 005 | 20231226032536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0267906 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1156.xml |
| 035 | |a (DE-627)NLM346895693 | ||
| 035 | |a (NLM)36174029 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Watanabe, Hiroki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease |b From the CREDO-Kyoto PCI/CABG registry Cohort-3 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.10.2022 | ||
| 500 | |a Date Revised 04.10.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a AIMS: There is a scarcity of studies comparing percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES) with coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease | ||
| 520 | |a METHODS AND RESULTS: The CREDO-Kyoto PCI/CABG registry Cohort-3 enrolled 14927 consecutive patients who underwent first coronary revascularization with PCI or isolated CABG between January 2011 and December 2013. The current study population consisted of 2464 patients who underwent multi-vessel coronary revascularization including revascularization of left anterior descending coronary artery (LAD) either with PCI using new-generation DES (N = 1565), or with CABG (N = 899). Patients in the PCI group were older and more often had severe frailty, but had less complex coronary anatomy, and less complete revascularization than those in the CABG group. Cumulative 5-year incidence of a composite of all-cause death, myocardial infarction or stroke was not significantly different between the 2 groups (25.0% versus 21.5%, P = 0.15). However, after adjusting confounders, the excess risk of PCI relative to CABG turned to be significant for the composite endpoint (HR 1.27, 95%CI 1.04-1.55, P = 0.02). PCI as compared with CABG was associated with comparable adjusted risk for all-cause death (HR 1.22, 95%CI 0.96-1.55, P = 0.11), and stroke (HR 1.17, 95%CI 0.79-1.73, P = 0.44), but with excess adjusted risk for myocardial infarction (HR 1.58, 95%CI 1.05-2.39, P = 0.03), and any coronary revascularization (HR 2.66, 95%CI 2.06-3.43, P<0.0001) | ||
| 520 | |a CONCLUSIONS: In this observational study, PCI with new-generation DES as compared with CABG was associated with excess long-term risk for major cardiovascular events in patients who underwent multi-vessel coronary revascularization including LAD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 700 | 1 | |a Yamamoto, Ko |e verfasserin |4 aut | |
| 700 | 1 | |a Shiomi, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Morimoto, Takeshi |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Eri |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumura, Yukiko |e verfasserin |4 aut | |
| 700 | 1 | |a Nakatsuma, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Takeji, Yasuaki |e verfasserin |4 aut | |
| 700 | 1 | |a Yaku, Hidenori |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Erika |e verfasserin |4 aut | |
| 700 | 1 | |a Yamashita, Yugo |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshikawa, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Fuki, Masayuki |e verfasserin |4 aut | |
| 700 | 1 | |a Yamaji, Kyohei |e verfasserin |4 aut | |
| 700 | 1 | |a Ehara, Natsuhiko |e verfasserin |4 aut | |
| 700 | 1 | |a Sakamoto, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Imada, Kazuaki |e verfasserin |4 aut | |
| 700 | 1 | |a Tada, Takeshi |e verfasserin |4 aut | |
| 700 | 1 | |a Taniguchi, Ryoji |e verfasserin |4 aut | |
| 700 | 1 | |a Nishikawa, Ryusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Tada, Tomohisa |e verfasserin |4 aut | |
| 700 | 1 | |a Uegaito, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Ogawa, Tatsuya |e verfasserin |4 aut | |
| 700 | 1 | |a Yamada, Miho |e verfasserin |4 aut | |
| 700 | 1 | |a Takeda, Teruki |e verfasserin |4 aut | |
| 700 | 1 | |a Eizawa, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Tamura, Nobushige |e verfasserin |4 aut | |
| 700 | 1 | |a Tambara, Keiichi |e verfasserin |4 aut | |
| 700 | 1 | |a Suwa, Satoru |e verfasserin |4 aut | |
| 700 | 1 | |a Shirotani, Manabu |e verfasserin |4 aut | |
| 700 | 1 | |a Tamura, Toshihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Inoko, Moriaki |e verfasserin |4 aut | |
| 700 | 1 | |a Nishizawa, Junichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Natsuaki, Masahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Sakai, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Kanemitsu, Naoki |e verfasserin |4 aut | |
| 700 | 1 | |a Ohno, Nobuhisa |e verfasserin |4 aut | |
| 700 | 1 | |a Ishii, Katsuhisa |e verfasserin |4 aut | |
| 700 | 1 | |a Marui, Akira |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuneyoshi, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Terai, Yasuhiko |e verfasserin |4 aut | |
| 700 | 1 | |a Nakayama, Shogo |e verfasserin |4 aut | |
| 700 | 1 | |a Yamazaki, Kazuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Mamoru |e verfasserin |4 aut | |
| 700 | 1 | |a Tamura, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Esaki, Jiro |e verfasserin |4 aut | |
| 700 | 1 | |a Miki, Shinji |e verfasserin |4 aut | |
| 700 | 1 | |a Onodera, Tomoya |e verfasserin |4 aut | |
| 700 | 1 | |a Mabuchi, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Furukawa, Yutaka |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, Masaru |e verfasserin |4 aut | |
| 700 | 1 | |a Komiya, Tatsuhiko |e verfasserin |4 aut | |
| 700 | 1 | |a Soga, Yoshiharu |e verfasserin |4 aut | |
| 700 | 1 | |a Hanyu, Michiya |e verfasserin |4 aut | |
| 700 | 1 | |a Ando, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Kadota, Kazushige |e verfasserin |4 aut | |
| 700 | 1 | |a Minatoya, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Nakagawa, Yoshihisa |e verfasserin |4 aut | |
| 700 | 1 | |a Kimura, Takeshi |e verfasserin |4 aut | |
| 700 | 0 | |a On behalf the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PloS one |d 2006 |g 17(2022), 9 vom: 12., Seite e0267906 |w (DE-627)NLM167327399 |x 1932-6203 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2022 |g number:9 |g day:12 |g pages:e0267906 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.pone.0267906 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2022 |e 9 |b 12 |h e0267906 | ||